Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Morgan Stanley (MS) Price & Performance

Axogen IncTrade
Morgan StanleyTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Morgan Stanley — how do they compare? Axogen Inc trades at $48.26 (market cap $2.61B), while Morgan Stanley trades at $219.37 (market cap $338.09B). The key difference: Morgan Stanley is far larger — about 129.5× Axogen Inc's market cap, and Morgan Stanley pays a 2.14% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNMS
Market Cap
$2.61B$338.09B
Sector
TechnologyFinancials
52-Week High
$48.48$228.42
52-Week Low
$14.16$144.04
Enterprise Value
$2.52B
Dividend Yield
2.14%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

No Aura AI signal available yet.

Morgan Stanley

Morgan Stanley (MS) trades at $215.27, down 0.46% on the day, with a neutral technical signal. The stock shows strong fundamentals, with revenue growing from $50.2B in 2022 to $66.0B in 2025 and net income margin expanding to 27.59%. Recent earnings beats and the selection to lead the Anthropic IPO highlight operational strength. The consensus analyst price target is $239.58, implying potential upside.

The outlook is positive, supported by earnings momentum and strategic initiatives like AI integration in wealth management. Key risks include volatile cash flows from operations and high leverage, with debt-to-asset ratio rising to 26.1 in 2025. Analyst sentiment is bullish, with 55.77% recommending Buy.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.

Read more on MS